Psychiatric consequences and issues of long COVID on patients with prior psychiatric comorbidities: a scoping review.
SARS-CoV-2
long COVID
mental health
psychiatric history
psychiatric symptoms
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
03
2023
accepted:
24
05
2023
medline:
23
6
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
epublish
Résumé
SARS-CoV-2 is a growing field of research and mental health in long COVID is one of its interesting domains. This scoping review aims at studying the outcomes of mental health in patients already known for psychiatric illness. This was done by researching the literature in two databases (Embase and PubMed) for articles studying mental health consequences of long COVID in patients already known for psychiatric history. Eleven studies were included. 6/11 studies found an effect of long COVID, with varying severity of outcomes studied, with either a worsening in length or severity. 4/11 did not find any correlation between worsening symptoms and psychiatric history. The methods for assessing which psychiatric symptoms to include and how to determine prior history were heterogeneous, making direct comparison sometimes difficult. The data seem to show worse effects of long COVID on mental health of patients with prior mental illness, with limitations regarding the heterogeneity of the studies' designs and focuses. It also highlights how neglected this population of patients is in the current state of research.
Identifiants
pubmed: 37351002
doi: 10.3389/fpsyt.2023.1181767
pmc: PMC10282140
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1181767Informations de copyright
Copyright © 2023 Hovagemyan, Dugerdil, Braggion, Mallet and Flahault.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Br J Psychiatry. 2021 Jun;218(6):334-343
pubmed: 33228822
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMJ. 2021 May 10;373:n972
pubmed: 33972268
JAMA Psychiatry. 2021 Jun 1;78(6):682-683
pubmed: 33769431
J Formos Med Assoc. 2022 Aug;121(8):1605-1609
pubmed: 35221145
Clin Psychol Rev. 2007 Dec;27(8):959-85
pubmed: 17448579
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
Maturitas. 2014 Oct;79(2):136-41
pubmed: 24713453
Mol Psychiatry. 2021 Sep;26(9):5199-5212
pubmed: 33536545
Early Interv Psychiatry. 2022 Oct;16(10):1159-1162
pubmed: 34796667
J Pers Med. 2022 Oct 26;12(11):
pubmed: 36579511
J Neurol Sci. 2022 Mar 15;434:120162
pubmed: 35121209
Exp Ther Med. 2022 May;23(5):363
pubmed: 35493431
F1000Res. 2020 Jun 23;9:636
pubmed: 33093946
Lancet Psychiatry. 2021 Aug;8(8):647-650
pubmed: 34087112
Int Clin Psychopharmacol. 2022 Jan 1;37(1):25-28
pubmed: 34686643
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110341
pubmed: 33940097
Infect Drug Resist. 2022 Aug 22;15:4697-4705
pubmed: 36034176
Eur Neuropsychopharmacol. 2022 Jan;54:1-6
pubmed: 34634679
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Neurosci Lett. 2018 Mar 16;669:68-74
pubmed: 27109788
Psychiatry Res. 2022 Aug;314:114677
pubmed: 35716481
Lancet Psychiatry. 2022 Oct;9(10):815-827
pubmed: 35987197
Brain Sci. 2021 Nov 02;11(11):
pubmed: 34827455
Diagnosis (Berl). 2021 Jul 02;8(4):403-412
pubmed: 34214386